ELYXYB is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy. The primary component is Celecoxib.
| Product ID | 43598-866_a864ef99-fd9f-2b3d-2cb1-dd6f44f6af82 |
| NDC | 43598-866 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ELYXYB |
| Generic Name | Celecoxib |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-10-05 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212157 |
| Labeler Name | Dr. Reddy |
| Substance Name | CELECOXIB |
| Active Ingredient Strength | 25 mg/mL |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-10-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43598-866 | ELYXYB | ELYXYB |
| 0025-1515 | CELEBREX | Celecoxib |
| 0025-1520 | CELEBREX | Celecoxib |
| 0025-1525 | CELEBREX | Celecoxib |
| 0025-1530 | CELEBREX | Celecoxib |
| 0093-7165 | Celecoxib | Celecoxib |
| 0093-7166 | Celecoxib | Celecoxib |
| 0093-7170 | Celecoxib | Celecoxib |
| 0093-7306 | Celecoxib | Celecoxib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ELYXYB 97518332 not registered Live/Pending |
Collegium Pharmaceutical, Inc. 2022-07-25 |
![]() ELYXYB 88294114 not registered Live/Pending |
Dr. Reddy's Laboratories Ltd. 2019-02-08 |